Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC began the process to unionize back in 2023, raising concerns about their access to telework, potential politicization of the civil service and other issues.
The Federal Trade Commission says a $48 million settlement should put an end to what it calls "predatory" tactics by the ...
Federal regulators have filed an administrative complaint against the St. Louis-based pharmacy benefit manager. Patients and ...
As the youngest ever Federal Trade Commission chair, Lina Khan has taken on scores of companies and preached the perils of business monopolies. Her pursuit of big business represents a policy ...
Photo: Andrew Caballero-Reynolds/AFP/Getty Images Lina Khan claims she’s trying to lower prices, but the Federal Trade Commission Chair’s attacks on business often do the opposite. Consider ...
The FTC launches Operation AI Comply to combat deceptive AI practices, targeting companies like DoNotPay and Ascend Ecom for ...
Amid intense focus on AI and a flurry of consumer privacy law updates, legislative activity has continued to change data breach ...
Ohio Attorney General Dave Yost and 11 other Republican attorneys general on Monday filed a brief in federal court in ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
On Oct. 7, the 5th Circuit Court of Appeals will hear arguments in a case that could significantly reshape how auto dealerships operate. The National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback